Sean Nolan
2022
In 2022, Sean Nolan earned a total compensation of $1.9M as Chief Executive Officer and Director at Taysha Gene Therapies.
Compensation breakdown
| Option Awards | $1,800,276 |
|---|---|
| Salary | $25,000 |
| Other | $74,000 |
| Total | $1,899,276 |
Nolan received $1.8M in option awards, accounting for 95% of the total pay in 2022.
Nolan also received $25K in salary and $74K in other compensation.
Rankings
In 2022, Sean Nolan's compensation ranked 1,839th out of 5,753 executives tracked by ExecPay. In other words, Nolan earned more than 68.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,839 out of 5,753 | 68th |
Division Manufacturing | 966 out of 3,133 | 69th |
Major group Chemicals And Allied Products | 397 out of 1,419 | 72nd |
Industry group Drugs | 362 out of 1,320 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 89 out of 291 | 69th |
Source: SEC filing on May 8, 2023.
Nolan's colleagues
We found three more compensation records of executives who worked with Sean Nolan at Taysha Gene Therapies in 2022.